Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials-Reference-Cited by-同舟云学术

Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials

Published:2020-05-08 Issue:4 Volume:18 Page:763-769
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Saba Corey F.¹^ORCID,Clifford Craig²,Burgess Kristine³^ORCID,Phillips Brenda⁴,Vail David⁵,Wright Zachary⁶,Curran Katie⁷,Fan Timothy⁸,Elmslie Robyn⁹,Post Gerald¹⁰,Thamm Douglas¹¹

Affiliation:

1. College of Veterinary Medicine, Department of Small Animal Medicine & Surgery University of Georgia Athens Georgia USA

2. Hope Veterinary Specialists Malvern Pennsylvania USA

3. Department of Clinical Sciences Cummings School of Veterinary Medicine at Tufts University North Grafton Massachusetts USA

4. Veterinary Specialty Hospital of San Diego San Diego California USA

5. School of Veterinary Medicine, Department of Medical Sciences University of Wisconsin‐Madison Madison Wisconsin USA

6. VCA Animal Diagnostic Clinic Dallas Texas USA

7. Carlson College of Veterinary Medicine, Department of Clinical Sciences Oregon State University Corvallis Oregon USA

8. College of Veterinary Medicine, Department of Veterinary Clinical Medicine University of Illinois at Urbana‐Champaign Urbana Illinois USA

9. VRCC Veterinary Specialty & Emergency Hospital Englewood Colorado USA

10. Chief Medical Officer FidoCure Palo Alto CA

11. Colorado State University Flint Animal Cancer Centre Fort Collins Colorado USA

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12605

Reference31 articles.

1. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases;Dorn CR;J Natl Cancer Inst,1968

2. Evaluation of a High-Dose Chemotherapy Protocol with No Maintenance Therapy for Dogs with Lymphoma

3. Evaluation of a 6-Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with Lymphoma

4. Evaluation of a Discontinuous Treatment Protocol (VELCAP-S) for Canine Lymphoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma;Veterinary and Comparative Oncology;2024-04-14

2. Use of genome‐wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high‐grade B‐cell lymphoma;Journal of Veterinary Internal Medicine;2023-12-19

3. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

4. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

5. High-Dose Conventional Chemotherapy;Therapeutic Strategies in Veterinary Oncology;2023-08-23